Clinical factors associated with BRCA1 pathogenic variants included a family history of breast cancer and hormone receptor status of the tumor, while for BRCA2, the only statistically significant clinical factor was a family history of breast cancer. This evidence concerns the gene BRCA2 and breast cancer.